HK1058902A1 - Compositions for protein delivery via the pulmonary route - Google Patents

Compositions for protein delivery via the pulmonary route

Info

Publication number
HK1058902A1
HK1058902A1 HK04101670A HK04101670A HK1058902A1 HK 1058902 A1 HK1058902 A1 HK 1058902A1 HK 04101670 A HK04101670 A HK 04101670A HK 04101670 A HK04101670 A HK 04101670A HK 1058902 A1 HK1058902 A1 HK 1058902A1
Authority
HK
Hong Kong
Prior art keywords
compositions
delivery via
protein delivery
pulmonary route
formulations
Prior art date
Application number
HK04101670A
Inventor
Stephen Francis Goodall
John Waters Michael
Stephen Michael Mahler
Hak-Kim Chan
Nora Y K Chew
Original Assignee
Injet Digital Aerosols Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23126170&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1058902(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Injet Digital Aerosols Ltd filed Critical Injet Digital Aerosols Ltd
Publication of HK1058902A1 publication Critical patent/HK1058902A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A61M11/041—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
    • A61M11/042—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters electrical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/02—Inhalators with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
    • A61M15/025—Bubble jet droplet ejection devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Abstract

Novel formulations comprising therapeutic agents, a surface tension-controlling agent, and a component that comprises both a humectant and a viscosity-controlling agent for use in thermal droplet ejecting devices are disclosed. The formulations are useful for maintaining controlled and reliable dosage of the therapeutic agent via pulmonary delivery.
HK04101670A 2001-05-21 2004-03-05 Compositions for protein delivery via the pulmonary route HK1058902A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29278301P 2001-05-21 2001-05-21
PCT/US2002/016233 WO2002094342A2 (en) 2001-05-21 2002-05-21 Compositions for protein delivery via the pulmonary route

Publications (1)

Publication Number Publication Date
HK1058902A1 true HK1058902A1 (en) 2004-06-11

Family

ID=23126170

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04101670A HK1058902A1 (en) 2001-05-21 2004-03-05 Compositions for protein delivery via the pulmonary route

Country Status (12)

Country Link
US (2) US20030064052A1 (en)
EP (1) EP1389137B1 (en)
JP (2) JP5342730B2 (en)
CN (1) CN1236831C (en)
AT (1) ATE333290T1 (en)
AU (1) AU2002310054B2 (en)
CA (1) CA2448022C (en)
DE (1) DE60213228T2 (en)
DK (1) DK1389137T3 (en)
ES (1) ES2268044T3 (en)
HK (1) HK1058902A1 (en)
WO (1) WO2002094342A2 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4147234B2 (en) 2004-09-27 2008-09-10 キヤノン株式会社 Discharge liquid, discharge method, cartridge, and discharge device
US20030072717A1 (en) * 2001-02-23 2003-04-17 Vapotronics, Inc. Inhalation device having an optimized air flow path
EP1389137B1 (en) * 2001-05-21 2006-07-19 InJet Digital Aerosols Limited Compositions for protein delivery via the pulmonary route
MXPA04006709A (en) 2002-01-11 2004-10-04 Sankyo Co Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these.
US7683029B2 (en) * 2003-05-07 2010-03-23 Philip Morris Usa Inc. Liquid aerosol formulations containing insulin and aerosol generating devices and methods for generating aerosolized insulin
US7910617B2 (en) 2004-02-24 2011-03-22 Sankyo Company, Limited Method for suppressing the number of peripheral blood lymphocytes using an amino alcohol compound
JP4564936B2 (en) * 2006-03-27 2010-10-20 キヤノン株式会社 Discharge liquid, discharge method, droplet forming method, liquid discharge cartridge, and discharge apparatus
JP4147235B2 (en) * 2004-09-27 2008-09-10 キヤノン株式会社 Discharge liquid, discharge method, droplet forming method, liquid discharge cartridge, and discharge apparatus
JP4646669B2 (en) 2005-03-30 2011-03-09 キヤノン株式会社 Discharge liquid, discharge method, droplet forming method, cartridge, and discharge device
JP4689340B2 (en) * 2005-05-02 2011-05-25 キヤノン株式会社 Liquid pharmaceutical composition for discharge
CN100394981C (en) * 2005-09-16 2008-06-18 深圳市孚沃德生物技术有限公司 Human granulocyte-macrophage colony stimulating factor spray and its prepn process
TWI299993B (en) * 2005-12-15 2008-08-21 Dev Center Biotechnology Aqueous inhalation pharmaceutical composition
JP2007254421A (en) * 2006-03-24 2007-10-04 Canon Inc Liquid for jetting, method of jetting, cartridge for jetting, jetting apparatus and method of preparing drops from liquid for jetting
JP4777225B2 (en) 2006-12-04 2011-09-21 キヤノン株式会社 Discharge liquid and discharge method
US10100098B2 (en) 2006-12-13 2018-10-16 Stelis Biopharma Private Limited Insulin production methods and proinsulin constructs
US20120214964A1 (en) * 2011-02-23 2012-08-23 Elona Biotechnologies Liquid insulin compositions and methods of making the same
JP5110898B2 (en) * 2007-02-16 2012-12-26 キヤノン株式会社 Discharge liquid and discharge method
AU2008334605B2 (en) * 2007-12-13 2013-07-18 Glaxo Group Limited Polypeptides, antibody variable domains & antagonists
CA2742710A1 (en) 2008-11-04 2010-05-14 Janssen Pharmaceutica Nv Crhr2 peptide agonists and uses thereof
EP2424669B1 (en) * 2009-04-29 2020-06-03 Sicpa Holding Sa Method for depositing a biological fluid onto a substrate
JP2013510167A (en) 2009-11-04 2013-03-21 ヤンセン ファーマシューティカ エヌ．ベー． Treatment of heart failure with stress-copin-like peptides
US10034988B2 (en) 2012-11-28 2018-07-31 Fontem Holdings I B.V. Methods and devices for compound delivery
US10194693B2 (en) 2013-09-20 2019-02-05 Fontem Holdings 1 B.V. Aerosol generating device
US11730191B2 (en) 2019-12-15 2023-08-22 Shaheen Innovations Holding Limited Hookah device
EP3860696B1 (en) 2019-12-15 2024-04-10 Shaheen Innovations Holding Limited Ultrasonic mist inhaler
US11666713B2 (en) * 2019-12-15 2023-06-06 Shaheen Innovations Holding Limited Mist inhaler devices
US11944121B2 (en) 2019-12-15 2024-04-02 Shaheen Innovations Holding Limited Ultrasonic mist inhaler with capillary element
WO2021123867A1 (en) 2019-12-15 2021-06-24 Shaheen Innovations Holding Limited Ultrasonic mist inhaler
US11672928B2 (en) 2019-12-15 2023-06-13 Shaheen Innovations Holding Limited Mist inhaler devices
US11589610B2 (en) 2019-12-15 2023-02-28 Shaheen Innovations Holding Limited Nicotine delivery device having a mist generator device and a driver device
US11730193B2 (en) 2019-12-15 2023-08-22 Shaheen Innovations Holding Limited Hookah device
US20230188901A1 (en) 2021-12-15 2023-06-15 Shaheen Innovations Holding Limited Apparatus for transmitting ultrasonic waves

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US455614A (en) * 1891-07-07 Sivioking device
US37053A (en) * 1862-12-02 Improved me at-cutter
US1105934A (en) * 1913-07-12 1914-08-04 Ernest J Stevens Inhaler.
US1272579A (en) * 1918-01-26 1918-07-16 George W Todd Dispensing-receptacle for liquid anesthetics.
US2084299A (en) * 1934-12-15 1937-06-15 Arthur G Borden Medicament holder for nasal inhalers
US2086588A (en) * 1935-11-18 1937-07-13 Joseph J Tobin Vaporizing applicator
US2449853A (en) * 1947-08-05 1948-09-21 Karp George Inhaler
DE2160561C3 (en) * 1971-12-07 1985-05-15 Hanns-Joachim Dr. 5000 Köln Hirtz Device for treating the respiratory tract with warm air
US3812854A (en) * 1972-10-20 1974-05-28 A Michaels Ultrasonic nebulizer
DE2445791C2 (en) * 1974-09-25 1984-04-19 Siemens AG, 1000 Berlin und 8000 München Ultrasonic liquid atomizer
JPS5953565A (en) * 1982-09-20 1984-03-28 Dainippon Toryo Co Ltd Jet ink composition
US4685968A (en) * 1985-12-05 1987-08-11 Hewlett-Packard Company Process for preparing ink compositions for ink-jets printers
US4653494A (en) * 1985-12-20 1987-03-31 Ruderian Max J Nasal inhalation system
US4694302A (en) * 1986-06-06 1987-09-15 Hewlett-Packard Company Reactive ink-jet printing
US4735217A (en) * 1986-08-21 1988-04-05 The Procter & Gamble Company Dosing device to provide vaporized medicament to the lungs as a fine aerosol
US5047064A (en) * 1987-06-03 1991-09-10 Sandoz Ltd. Method and composition for the alkali treatment of cellulosic substrates
US4922901A (en) * 1988-09-08 1990-05-08 R. J. Reynolds Tobacco Company Drug delivery articles utilizing electrical energy
JP2931846B2 (en) * 1988-11-07 1999-08-09 松下電器産業株式会社 Panel switch and manufacturing method thereof
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5062892A (en) * 1989-10-27 1991-11-05 Hewlett-Packard Company Ink additives for improved ink-jet performance
US5060671A (en) * 1989-12-01 1991-10-29 Philip Morris Incorporated Flavor generating article
US5144962A (en) * 1989-12-01 1992-09-08 Philip Morris Incorporated Flavor-delivery article
US5152456A (en) * 1989-12-12 1992-10-06 Bespak, Plc Dispensing apparatus having a perforate outlet member and a vibrating device
US5047084A (en) * 1990-01-23 1991-09-10 Hewlett-Packard Company Microemulsion ink jet ink composition
EP0462305B1 (en) * 1990-06-21 1994-11-02 Huland, Edith, Dr. Dr. Aerosol containing cytokines and use thereof
DE4026072A1 (en) * 1990-08-17 1992-02-20 Sanol Arznei Schwarz Gmbh NITROGLYCER-CONTAINING, HYDROPHILIC, WAESSRING PUMPSPRAY
GB9027363D0 (en) * 1990-12-18 1991-02-06 Gillette Co Shampoo compositions
US5450336A (en) * 1991-03-05 1995-09-12 Aradigm Corporation Method for correcting the drift offset of a transducer
JP3532204B2 (en) * 1991-03-05 2004-05-31 アラダイム コーポレーション Method and apparatus for correcting drift offset of a flow sensor pressure sensor
US5404871A (en) * 1991-03-05 1995-04-11 Aradigm Delivery of aerosol medications for inspiration
US5505214A (en) * 1991-03-11 1996-04-09 Philip Morris Incorporated Electrical smoking article and method for making same
US5120528A (en) * 1991-06-12 1992-06-09 Block Drug Company, Inc. Taste preserving, mild oral hygiene compositions
US5413732A (en) * 1991-08-19 1995-05-09 Abaxis, Inc. Reagent compositions for analytical testing
US5170782A (en) * 1991-09-12 1992-12-15 Devilbiss Health Care, Inc. Medicament nebulizer with improved aerosol chamber
DE4134665A1 (en) * 1991-10-19 1993-04-22 Solvay Deutschland MEDICAL INHALATION SYSTEM
GB2265845B (en) * 1991-11-12 1996-05-01 Medix Ltd A nebuliser and nebuliser control system
US5206219A (en) * 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments
US5639441A (en) * 1992-03-06 1997-06-17 Board Of Regents Of University Of Colorado Methods for fine particle formation
FR2690634B1 (en) * 1992-04-29 1994-10-14 Chronotec Micro-spray device generated by ultrasonic waves.
JP3178945B2 (en) * 1992-08-25 2001-06-25 日本碍子株式会社 Inkjet print head
GB9225098D0 (en) * 1992-12-01 1993-01-20 Coffee Ronald A Charged droplet spray mixer
DE4300880C2 (en) * 1993-01-15 1996-03-21 Draegerwerk Ag Ultrasonic nebulizer with dosing unit
US5724957A (en) * 1993-01-29 1998-03-10 Aradigm Corporation Intrapulmonary delivery of narcotics
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
US5429302A (en) * 1993-05-19 1995-07-04 Fisons Corporation Nebulizing element and device
US5666977A (en) * 1993-06-10 1997-09-16 Philip Morris Incorporated Electrical smoking article using liquid tobacco flavor medium delivery system
ES2171455T3 (en) * 1993-06-29 2002-09-16 Ponwell Entpr Ltd DISPENSER.
EP0710102A1 (en) * 1993-07-19 1996-05-08 Amgen Inc. Stabilization of aerosolized proteins
US5388574A (en) * 1993-07-29 1995-02-14 Ingebrethsen; Bradley J. Aerosol delivery article
US5514670A (en) * 1993-08-13 1996-05-07 Pharmos Corporation Submicron emulsions for delivery of peptides
US6228383B1 (en) * 1994-03-03 2001-05-08 Gs Development Ab Use of fatty acid esters as bioadhesive substances
ATE180971T1 (en) * 1994-03-30 1999-06-15 Gs Dev Ab USE OF FATTY ACID ESTERS AS BIO ADHESIVES
WO1996028205A1 (en) * 1995-03-14 1996-09-19 Siemens Aktiengesellschaft Ultrasonic atomizer device with removable precision dosing unit
US5808637A (en) * 1995-05-26 1998-09-15 Hewlett-Packard Company Method and apparatus for ink drop trajectory control
US5715866A (en) * 1995-12-29 1998-02-10 Granger; Melforde A. Portable fluid dispensing apparatus
US6026809A (en) * 1996-01-25 2000-02-22 Microdose Technologies, Inc. Inhalation device
US5694920A (en) * 1996-01-25 1997-12-09 Abrams; Andrew L. Inhalation device
USRE37053E1 (en) * 1996-05-24 2001-02-13 Massachusetts Institute Of Technology Particles incorporating surfactants for pulmonary drug delivery
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US5934289A (en) * 1996-10-22 1999-08-10 Philip Morris Incorporated Electronic smoking system
EP1319651B1 (en) * 1997-04-04 2005-06-29 Mitsubishi Pharma Corporation 2-Aminopropane-1,3-diol compound, pharmaceutical use thereof and synthetic intermediates therefor
WO1998058909A1 (en) * 1997-06-25 1998-12-30 Teijin Limited Vitamin d3 derivatives and remedies for inflammatory respiratory diseases prepared from the same
US6946117B1 (en) * 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
AU757153B2 (en) * 1997-09-29 2003-02-06 Novartis Ag Stabilized preparations for use in metered dose inhalers
EP1029536B1 (en) * 1997-10-01 2007-11-28 Novadel Pharma Inc. Buccal non-polar spray
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
US6566345B2 (en) * 2000-04-28 2003-05-20 Fziomed, Inc. Polyacid/polyalkylene oxide foams and gels and methods for their delivery
JP4147234B2 (en) * 2004-09-27 2008-09-10 キヤノン株式会社 Discharge liquid, discharge method, cartridge, and discharge device
US6767637B2 (en) * 2000-12-13 2004-07-27 Purdue Research Foundation Microencapsulation using ultrasonic atomizers
EP1389137B1 (en) * 2001-05-21 2006-07-19 InJet Digital Aerosols Limited Compositions for protein delivery via the pulmonary route
CA2497845C (en) * 2002-09-06 2012-08-14 Chrysalis Technologies Incorporated Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols

Also Published As

Publication number Publication date
JP2011042695A (en) 2011-03-03
JP5342730B2 (en) 2013-11-13
WO2002094342A2 (en) 2002-11-28
CA2448022A1 (en) 2002-11-28
US20030064052A1 (en) 2003-04-03
WO2002094342A3 (en) 2003-03-20
US20090022669A1 (en) 2009-01-22
ATE333290T1 (en) 2006-08-15
ES2268044T3 (en) 2007-03-16
DE60213228T2 (en) 2007-06-21
EP1389137A2 (en) 2004-02-18
JP2004532861A (en) 2004-10-28
EP1389137B1 (en) 2006-07-19
CN1236831C (en) 2006-01-18
DE60213228D1 (en) 2006-08-31
AU2002310054B2 (en) 2007-02-01
CA2448022C (en) 2013-11-12
EP1389137A4 (en) 2005-01-05
DK1389137T3 (en) 2006-10-30
CN1464791A (en) 2003-12-31

Similar Documents

Publication Publication Date Title
HK1058902A1 (en) Compositions for protein delivery via the pulmonary route
ZA200405657B (en) Formulation & dosage form for the controlled delivery of therapeutic agents.
BR9917089A (en) Compositions and methods for mucosal distribution
IL153297A0 (en) Compounds and compositions for delivering active agents
EP1476138A4 (en) Modified release formulations of at least one form of tramadol
MXPA03003238A (en) Anhydrous dentifrice formulations for the delivery of incompatible ingredients.
WO2003045306A3 (en) Phenoxy amine compounds and compositions for delivering active agents
WO2001062737A3 (en) Amino pyrazole derivatives useful for the treatment of obesity and other disorders
EP1246792A4 (en) Compounds and compositions for delivering active agents
AU2003229084A1 (en) Methods and formulations for the delivery of pharmacologically active agents
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
AU2001284985A1 (en) Compounds and compositions for delivering active agents
AU7653801A (en) Device for delivering physiologically active agent in powdered form
WO2002015959A3 (en) Compounds and compositions for delivering active agents
SG149054A1 (en) Multiparticulate formulations for oral delivery
WO2004066983A3 (en) Controlled release of highly soluble agents
WO2002043706A3 (en) Prolamin-based sustained-release compositions and delayed-onset compositions
HUP0402028A3 (en) Unsaturated 1-amino-alkylcyclohexane derivatives, pharmaceutical compositions containing them and use thereof
AU2002316200A1 (en) Compound and composition for delivering active agents
SE0103210D0 (en) New formulations and use thereof
AU2002220654A1 (en) Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders
ATE286716T1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING SALMETEROL
HUP0402149A3 (en) Water-soluble phenylpyridazine derivatives, their use and pharmaceutical compositions containing the same
DE60318182D1 (en) AEROSOL FORMULATIONS WITH ESTERS OF 3,17-DIHYDROXY-ESTRATRIENE DERIVATIVES FOR PULMONARY DELIVERY
AU2002302684A1 (en) Film-forming composition for topical use and use thereof for delivering active agents

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140521